Treatment of coronary stent thrombosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Treatment of coronary stent thrombosis
Coronary stent thrombosis may cause myocardial ischemia or infarction and hence treatment strategies are similar to that of myocardial infarction. Emergent target lesion or target vessel revascularization is the treatment of choice in stent thrombosis. Revascularization may be carried out by PCI or in some instances, thrombolytics [1]. If revascularization is not successful, urgent CABG should be considered.
If revascularization with stent placement is planned, risks and benefits of DES vs BMS should be carefully assessed depending on risk of bleeding and patient compliance.
The probable cause of stent thrombosis should be evaluated as treatment may vary with etiology.
References
- ↑ Wenaweser P, Rey C, Eberli FR, Togni M, Tüller D, Locher S, Remondino A, Seiler C, Hess OM, Meier B, Windecker S (2005). "Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome". European Heart Journal. 26 (12): 1180–7. doi:10.1093/eurheartj/ehi135. PMID 15728650. Retrieved 2011-05-05. Unknown parameter
|month=ignored (help)